http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0000207-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C405-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C401-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B-
filingDate 1978-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d532423005938ac213af15d0f4f62b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7e7a001f3afcb2ebb20bd0f1df1e8c0
publicationDate 1979-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0000207-A1
titleOfInvention Prostaglandin derivatives, their preparation and pharmaceutical compositions and intermediates
abstract Prostaglandin derivatives of the form wherein R` is hydrogen or lower alkyl; R 2 hydroxy; R 3 is hydrogen; or R 2 and R 3 together oxo; R 4 is hydrogen or lower alkyl; R 5 is fluorine, lower alkyl or trifluoromethyl; R 6 is hydrogen, fluorine or lower alkyl; R 1 is hydrogen; R 8 hydroxy; or R 1 and R 8 together oxo; A and B, and X and Y, alone mean hydrogen or together represent a carbon-carbon bond; with the condition that R 2 and R 3 together are oxo when R 1 and R 8 are together oxo; and with the further condition that A and B represent hydrogen when R 7 is hydrogen; and with the third condition that X and Y represent a carbon-carbon bond when R 1 and R 1 are simultaneously hydrogen; their enantiomers and ranemates have therapeutic, for example hypotensive and anti-ulcerogenic effects.n n n The invention relates to such prestaglandin derivatives, their production and pharmaceutical preparations containing such prostaglandin derivatives, and to new intermediates for the production of these prostaglandin derivatives.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0310305-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0310305-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5204371-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5317032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0030377-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2210556-B
priorityDate 1977-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468112547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236560140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466368935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70572903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236739276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236743965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88769528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236740937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70611826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66671322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54446589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226710829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70611283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53818880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236562151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54525521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70612896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236560268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467047371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236558031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8980
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236559025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54492770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236559922

Total number of triples: 75.